<DOC>
	<DOC>NCT01850056</DOC>
	<brief_summary>The purpose of this study is to determine whether DEB is more effective than common PTA balloon in long-term vessel patency and inhibiting restenosis.</brief_summary>
	<brief_title>AcoArt â…  / SFA China</brief_title>
	<detailed_description />
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<criteria>Age between 18 and 80 years Patients with peripheral artery disease (PAD), with Rutherford classification between 2 and 5 an occlusion or a minimum grade of stenosisPrimary over 70% in the superficial femoral artery an /or the popliteal artery Total length of treat lesion(s)is less or equal to 40cm signed Patient informed consent form plasma Cr level greater than 150 umol/L in patients patients with acute thrombosis requiring lysis or thrombectomy patient with a lysis or an lower limb intervention as a therapy within the last 6 weeks patient requiring intervention in both lower limbs at the same time target lesion can't be cross by the guide wire distal outflow through less than one lower leg vessel known hypersensitivity to aspirin, heparin, clopidogrel,paclitaxel, contrast medium, etc. patients participating in another clinical trials with interfere with this trial in the past 3 months pregnancy and lactating woman untreatable bleeding diatheses other diseases, such as cancer, liver disease, or cardiac insufficiency, which may lead to protocol violations or markedly shorten a patients's life expectancy(less than 2 years) patients unable or unwilling to participate this trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>drug eluting balloon catheter</keyword>
</DOC>